Results 41 to 50 of about 7,084,111 (308)
International Journal of Surgery, 2020 An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization ...
C. Sohrabi +7 more
semanticscholar +1 more source
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Thrombosis Research, 2020 Introduction COVID-19 may predispose to both venous and arterial thromboembolism due to excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation.
F. Klok +10 more
semanticscholar +1 more source
Systematic Reviews, 2023 In this letter, we briefly describe how we selected and implemented the quality criteria checklist (QCC) as a critical appraisal tool in rapid systematic reviews conducted to inform public health advice, guidance and policy during the COVID-19 pandemic ...
Daphne Duval +5 more
doaj +1 more source
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
New England Journal of Medicine, 2020 BACKGROUND Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of the disease, relatively little is known about the associated morphologic ...
M. Ackermann +13 more
semanticscholar +1 more source
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea [PDF]
Osong Public Health and Research PerspectivesThe COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination.
Na-Young Jeong +14 more
doaj +1 more source
Evaluation of self-administered antigen testing in a college setting
Virology Journal, 2022 Background The objective of our investigation was to better understand barriers to implementation of self-administered antigen screening testing for SARS-CoV-2 at institutions of higher education (IHE).
Sarah C. Tinker +21 more
doaj +1 more source
Infectious Disease Reports, 2022 Background: The development of vaccines against COVID-19 has greatly altered the natural course of this infection, reducing the disease’s severity and patients’ hospitalization. However, hesitancy against vaccination remains an obstacle in the attempt to
Petros Ioannou +9 more
doaj +1 more source
Inflammation and Regeneration, 2020 Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in Wuhan, China, and has spread globally to most countries. In Japan, the first COVID-19 patient was identified on January 15, 2020.
Tokio Hoshina +8 more
doaj +1 more source
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
New England Journal of Medicine, 2020 Background No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection,
B. Cao +64 more
semanticscholar +1 more source
International Journal of Preventive Medicine, 2020 Coronaviruses (CoV) are RNA viruses that cause endemic infections in various species of mammals and avian birds. There are seven known human CoVs, each of which causes respiratory diseases: together account for about one third of common colds. Some CoVs have recently entered humans from infected animals and lastly we have SARS COVID-19, (CoV), which ...
Roberto Menicagli, Mario Limodio
openaire +3 more sources